Bladder Cancer | Topics

 
Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle- Invasive Bladder Cancer: A Population-Based Study, 2006-2017
January 20, 2022

Patients 70 years or older that received neoadjuvant chemotherapy and radical cystectomy had better overall survival than those undergoing radical cystectomy alone.

Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer
January 20, 2022

Jun Gong, MD, gives his perspective on neoadjuvant chemotherapy in elderly patients with muscle-invasive bladder cancer.

Future Treatment Landscape of Metastatic Urothelial Carcinoma
January 17, 2022

Closing their discussion on metastatic urothelial carcinoma, panelists reflect on novel agents and the future treatment paradigm.

Selecting Second-Line Therapy for Metastatic Urothelial Carcinoma
January 17, 2022

Expert perspectives on the selection of second-line therapy after a patient has progressed on maintenance avelumab.

mUC: Duration of Maintenance Avelumab and Treatment at Progression
January 10, 2022

Focused discussion on the duration of maintenance avelumab for metastatic urothelial carcinoma and considerations for switching therapy.

Metastatic Urothelial Carcinoma: Does FGFR Status Impact Use of Maintenance Avelumab?
January 10, 2022

A brief review of whether FGFR status in metastatic urothelial carcinoma should impact treatment approaches.

Metastatic Urothelial Carcinoma: Discussing Maintenance Therapy With Patients
January 03, 2022

Shared insight on how best to discuss maintenance therapy with patients being treated for metastatic urothelial carcinoma.

When to Use Maintenance Therapy in Metastatic Urothelial Carcinoma
January 03, 2022

Panelists consider whether the use of maintenance therapy is as prevalent after complete response or in patients with lesser PD-L1 expression.

Bladder Cancer Age-Standardized Death Rates Decreased Globally Between 1990 and 2019
December 22, 2021

Research suggests age-standardized incidence and death rates for patients with bladder cancer decreased globally between 1990 and 2019.

Metastatic Urothelial Carcinoma: Experience With Maintenance Avelumab
December 21, 2021

Experts highlight the benefits of frontline avelumab maintenance therapy in patients with metastatic urothelial carcinoma.